Meniere Hastalığında Güncel Tanı ve Tedavi

Year 2019, Volume: 28 Issue: 2, 170 - 176, 30.06.2019

Süleyman Özdemir Elvan Onan

Abstract

Meniere Hastalığı, epizodik spontan vertigo
atakları, genellikle tek taraflı fluktuasyon gösteren işitme kaybı, aural
dolgunluk ve tinnitus ile karakterize bir iç kulak hastalığıdır. Semptomlarının
çok iyi bilinmesine rağmen, günümüzde halen tanı konulması zor bir hastalıktır.
Kesin tanısı sadece postmortem inceleme ile histopatolojik olarak
konulabilmekte ve tedavisi de klinikler arası farklılıklar göstermektedir. Bu
makalede Meniere hastalığının tanı ve tedavisindeki son gelişmeler, yeni klavuz
ve metaanaliz çalışmaları gözden geçirilerek sunulmuştur.

Keywords

Meniere hastalığı, vertigo, tinnitus

Current Diagnosis and Treatment for Meniere's Disease

Abstract

Meniere's disease is an inner ear disease characterized by spontaneous episodic Vertigo attacks, usually unilateral fluctuating hearing loss, aural fullness and tinnitus. Although the symptoms are well known, the diagnosis of the disease is difficult still today. The certain diagnosis can be made only with postmortem histopathological examination and the treatment vary some differences between the clinics. In this article, we present the recent advances in the diagnosis and treatment of Meniere's disease by reviewing new guidelines and meta-analysis studies.

Keywords

Meniere’s disease, vertigo, tinnitus, diagnosis

References

• Referans1. Meniere MP. Maladies del I'oreille interne offranl les symptoms de la congestion cerebrale apoplectiforme. Gaz Med Paris 1861; 16:55-88.
• Referans2. Kulak Burun Boğaz Hastalıkları ve Baş-Boyun Cerrahisi. 2. Baskı. Edt: Prof. Dr.Can Koç. Bölüm 4.18: Meniere Hastalığı. S. Özdemir, M. Kıroğlu. Güneş Kitabevleri, Ankara, 2013.
• Referans3. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995 Sep;113(3):181-5.
• Referans4. Goebel JA. 2015 Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Ménière's Disease. Otolaryngol Head Neck Surg. 2016 Mar;154(3):403-4.
• Referans5. Gibson WP. The use of electrocochleography in the diagnosis of Meniére's disease. Acta Otolaryngol Suppl. 1991;485:46-52.
• Referans6. Kulak Burun Boğaz Hastalıkları ve Baş Boyun Cerrahisi. Çelik O ed. Bölüm: 1.13.Endolenfatik Hidrops. Akyıldız AN. 2.baskı, Asya Tıp Kitabevi,2007.
• Referans7. Mateijsen DJ, Hengel PW, Kingma H, Oreel MA, Wit HP, Albers FW. Vertigo and electronystagmography in uni- and bilateral Ménière's disease.ORL J Otorhinolaryngol Relat Spec. 2001 Nov-Dec;63(6):341-8.
• Referans8. Bell SL, Barker F, Heselton H, MacKenzie E, Dewhurst D, Sanderson A. A study of the relationship between the video head impulse test and air calorics. Eur Arch Otorhinolaryngol 2015; 272: 1287-294.
• Referans9. Özdek A, Keseroğlu K, Er S, Ünsal S, Gündüz M. Periferik Vestibüler Hastalıklarda o-VEMP ve v-HIT Test Sonuçlarının Kalorik Test Sonuçları İle Karşılaştırılması. JAREM 2017; 7: 26-31
• Referans10. Nakashima T, Naganawa S, Suguira M, et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 2007;117:415–20.
• Referans11. Nakashima T, Naganawa S, Pyykko I, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009:5–8.
• Referans12. Wang F1, Lyu H, Zhao M, Sha Y, Zhang F, Cheng Y, Huang W, Tang W, Xie Y, Lu P. Assessment of Cochlea Endolymphatic Hydrops Using 3-D FLAIR and 3-D Real IR Sequence in Guinea Pigs via 3T MRI After Intratympanic Gadolinium: A Histopathological Comparison. Otol Neurotol. 2017 Apr;38(4):585-590.
• Referans13. Bykowski J, Harris JP, Miller M, Du J, Mafee MF. Intratympanic Contrast in the Evaluation of Menière Disease: Understanding the Limits. AJNR Am J Neuroradiol. 2015 Jul;36(7):1326-32.
• Referans14. Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Meniere’s disease. J Vestib Res. 2015;25;1-7.
• Referans15. van Esch BF, van der Zaag-Loonen HJ, Bruintjes TD, van Benthem PP. Interventions for Ménière’s disease: protocol for an umbrella systematic review and a network meta-analysis. BMJ Open 2016;6:e010269.
• Referans16. Nevoux j, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V, International consensus (ICON) on treatment of Ménière’s disease. European Annals of Otorhinolaryngology, Head and Neck Diseases 2018;135:29-32.
• Referans17. van Esch BF, van der Scheer-Horst ES, van der Zaag-Loonen HJ, Bruintjes TD, et al. The effect of vestibular rehabilitation in patients with Ménière’s disease. Otolaryngol Head Neck Surg 2017;156:426–34.
• Referans18. Edelman S, Mahoney AE, Cremer PD. Cognitive behavior therapy for chronic subjective dizziness: a randomized, controlled trial. Am J Otolaryngol 2012;33:395–401.
• Referans19. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2015;1:CD005397.
• Referans20. Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood ow in Guinea pigs in vivo. PLoS One. 2012;7(6):e39086.
• Referans21. Adrion C, Fischer CS, Wagner J, Gürkov R, et al. Efficacy and safety of betahistine treatment in patients with Ménière’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 2016;352:h6816.
• Referans22. Kıroğlu MM, Dağkıran M, Özdemir S, Sürmelioğlu Ö, Tarkan Ö. The Effects of Betahistine and Dimenhydrinate on Caloric Test Parameters; Slow-Phase Velocity of Nystagmus. J Int Adv Otol 2014;10:68-71.
• Referans23. van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Ménière’s disease or syndrome. Cochrane Database Syst Rev 2015;3:CD008419.
• Referans24. Philips JS, Westerberg B. Intratympanic steroids for Ménière’s disease or syndrome. Cochrane Database Syst Rev 2011;7:CD008514.
• Referans25. Syed MI, Ilan O, Nassar J, Rutka JA. Intratympanic therapy in Ménière’s syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol 2015;40:682–90.
• Referans26. Prezant TR, Agapian JV, Bohlman MC, Bu X, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4:289–94.
• Referans27. Silverstein H, Wanamaker H, Flanzer J, Rosenberg S. Vestibular neurectomy in the United States 1990. Am J Otol 1992;13:23–30.